Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
about
Is there more to BARD1 than BRCA1?Linking the ovarian cancer transcriptome and immunomeProtein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes.Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue.Gene expression profiling of rat spermatogonia and Sertoli cells reveals signaling pathways from stem cells to niche and testicular cancer cells to surrounding stroma.HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or b.Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkersAssociation of three common BARD1 variants with cancer susceptibility: a system review and meta-analysis.BARD1 mediates TGF-β signaling in pulmonary fibrosis.Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome.Antagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability.Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma.Alternative splicing in cancer: implications for biology and therapy.Regulation of transcription by synthetic DNA-bending agents.Analysis of the antitumor activity of gemcitabine and carboplatin against ovarian clear-cell carcinoma using the DNA damage marker γH2AX.BARD1: an independent predictor of survival in non-small cell lung cancer.A sensitive test for the detection of specific DSB repair defects in primary cells from breast cancer specimens.BARD1 serum autoantibodies for the detection of lung cancer.Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling.Dualistic Role of BARD1 in Cancer.BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing.Preoperative high-intensity training in frail old patients undergoing pulmonary resection for NSCLC.Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer.Clinical diagnosis of malignant pleural mesothelioma.
P2860
Q28236135-7AD1F1D4-951F-4C8A-BFF8-2A70608553B8Q33313203-587FD85F-B81A-47D6-A57B-EEA89AEED55FQ33329750-F10D8678-7087-4C9E-9AE8-3CEE5DDF55A6Q33723629-44DC6810-C04F-47B3-AF79-ACA8D391432AQ33792623-4C82A246-8913-4A35-A5EA-7BA3B56668D4Q35070712-A02C6E6C-6D00-41AB-AD12-3DA07B1564AAQ35151124-BCC156D1-F053-4D8B-85C6-DBC76028299BQ35173448-B66F7794-EBB5-4D51-A0A5-75EA52421841Q36105254-278A2025-801A-43DF-869F-A13D1CD2C43EQ36166792-32F7EE3C-F238-4CAC-A213-694F12183248Q37705964-FC8CF347-F5EA-4537-B159-824E39CD9AC4Q37940719-B1ECC600-6F4C-4FB4-A4DC-5B110C53D0EEQ38179828-07C7FCD1-9653-42C9-A17F-F062B95FAFEEQ38309182-11CDCD9C-E1AA-4D3E-92EE-97DF15F01FF3Q39118191-87356DC5-DDEE-4F2A-99AC-AF688344AE4FQ39495392-DC09EE6C-CDFF-4662-92F3-C94E22A60C98Q39980425-75E5B7F5-B109-49CB-888A-C3A4F4B6CC04Q41281453-B17113B3-10BF-42B5-A94A-71BE4AECDF27Q41332112-2A209EBC-6698-4CFC-A1BE-45DFEDCB2A4EQ47177315-B3DAA992-673F-4F35-93E0-73646FFE82FFQ49612029-990A9A4D-8521-431C-91EB-9A00C51AD218Q51832091-B80B8EB2-7EDE-4B53-91B9-14CE74008E4CQ51837133-C86E8D6B-7836-41D9-B236-65322F48CD66Q52672895-F7AB0280-B6AD-43C2-A1E4-4D78D2E4E081
P2860
Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
@en
Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
@nl
type
label
Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
@en
Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
@nl
prefLabel
Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
@en
Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
@nl
P2093
P2860
P356
P1476
Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis
@en
P2093
Andrea Bianco
Anne-Therese Vlastos
Geoffrey J Laurent
Irmgard Irminger-Finger
Jian-Yu Wu
Karl-Heinz Krause
Marie-Françoise Pelte
P2860
P304
P356
10.1002/IJC.21428
P577
2006-03-01T00:00:00Z